We are live on ! Find out more
CAC

Cowen and Company Portfolio holdings

AUM $2.97B
1-Year Est. Return 105.26%
This Fund
S&P 500
This Quarter Est. Return
+10.51%
1 Year Est. Return
+105.26%
3 Year Est. Return
+120.05%
5 Year Est. Return
+670.56%
10 Year Est. Return
AUM
$1.21B
AUM Growth
+$355M
Cap. Flow
+$316M
Cap. Flow %
26.21%
Top 10 Hldgs %
40.06%
Holding
747
New
182
Increased
169
Reduced
181
Closed
163

Sector Composition

Rank Sector Weight
1 Healthcare 36.03%
2 Financials 28.77%
3 Technology 9.99%
4 Energy 5.75%
5 Consumer Discretionary 4.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNTM
701
DELISTED
Pontem Corporation
PNTM
-500,000
Closed -$5.17M
SGHL
702
DELISTED
Signal Hill Acquisition Corp. Class A Common Stock
SGHL
-136,853
Closed -$1.42M
SGHLW
703
DELISTED
Signal Hill Acquisition Corp. Warrant
SGHLW
-99,666
Closed -$5.96K
SIRE
704
DELISTED
Sisecam Resources LP
SIRE
-196,816
Closed -$4.94M
AXAC.RT
705
DELISTED
AXIOS Sustainable Growth Acquisition Corporation Rights to receive one-tenth (1/10) of one Class A ordinary share
AXAC.RT
-50,000
Closed -$9.5K
AXAC.WS
706
DELISTED
AXIOS Sustainable Growth Acquisition Corporation Redeemable warrants, each whole warrant exercisable for one Class A ordinary share at an exercise price of $11.50
AXAC.WS
-331,927
Closed -$11.6K
FOXO.WS
707
DELISTED
FOXO Technologies Inc. Redeemable Warrants, each whole warrant exercisable for one share of Class A Common Stock at an exercise price of $11.50
FOXO.WS
-182,350
Closed -$5.85K
TBMCU
708
DELISTED
Trailblazer Merger Corporation I Unit
TBMCU
-120,539
Closed -$1.22M
LVACW
709
DELISTED
LAVA Medtech Acquisition Corp. Warrants
LVACW
-50,300
Closed -$3.77K
BNNR
710
DELISTED
Banner Acquisition Corp. Class A Common Stock
BNNR
-133,833
Closed -$1.37M
GVCIW
711
DELISTED
Green Visor Financial Technology Acquisition Corp. I Warrants
GVCIW
-62,500
Closed -$6.25K
PGRWW
712
DELISTED
Progress Acquisition Corp. Warrant
PGRWW
-48,791
Closed -$2.68K
SVNAW
713
DELISTED
7 Acquisition Corp Warrant
SVNAW
-143,779
Closed -$20.1K
TGR
714
DELISTED
Kimbell Tiger Acquisition Corporation
TGR
-43,912
Closed -$462K
BRIVW
715
DELISTED
B. Riley Principal 250 Merger Corp. Warrant
BRIVW
-51,500
Closed -$3.41K
VLATW
716
DELISTED
Valor Latitude Acquisition Corp. Warrant
VLATW
-203,471
Closed -$8.14K
ADALW
717
DELISTED
Anthemis Digital Acquisitions I Corp Warrant
ADALW
-162,900
Closed -$5.78K
TRAQ.WS
718
DELISTED
Trine II Acquisition Corp. Redeemable Warrants, each whole warrant exercisable for one Class A Ordinary Share at an exercise price of $11.50 per share
TRAQ.WS
-119,372
Closed -$5.97K
TRAQ
719
DELISTED
Trine II Acquisition Corp.
TRAQ
-514,043
Closed -$5.38M
SKYAW
720
DELISTED
Skydeck Acquisition Corp. Warrants
SKYAW
-46,933
Closed -$1.52K
CIIGW
721
DELISTED
CIIG Capital Partners II, Inc. Warrant
CIIGW
-49,900
Closed -$6.24K
EUCRW
722
DELISTED
Eucrates Biomedical Acquisition Corp. Warrant
EUCRW
-202,371
Closed -$8.2K
NHIC
723
DELISTED
NewHold Investment Corp. II Class A Common Stock
NHIC
-127,698
Closed -$1.3M
NHICW
724
DELISTED
NewHold Investment Corp. II Warrant
NHICW
-89,700
Closed -$12.9K
IPVIW
725
DELISTED
InterPrivate IV InfraTech Partners Inc. Warrant
IPVIW
-100,000
Closed -$9K

Similar funds

Cowen and Company's Q2 2023 Portfolio in Review

As of Q2 2023, Cowen and Company held 747 positions worth $1.21B, up 42% from $851M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Cowen and Company deployed $316M of net new capital in Q2 2023, opening 182 new positions and adding to 169 existing holdings. Its largest new stake was NVIDIA: 1,927,500 shares worth $81.5M.

By sector, the portfolio is most concentrated in Healthcare at 36% of assets, down from 38% a quarter earlier, followed by Financials and Technology.

On the sell side, the largest reduction was Avadel Pharmaceuticals, an estimated $13.9M trimmed.

  • Cowen and Company's largest Q2 2023 buy was NVIDIA: 1,927,500 shares worth $81.5M.
  • Cowen and Company added most to Ares Acquisition Corporation in Q2 2023, an estimated $15.9M increase.
  • Cowen and Company's biggest Q2 2023 reduction was Avadel Pharmaceuticals, cutting an estimated $13.9M.
  • Cowen and Company fully exited Sylvamo in Q2 2023, selling an estimated $99.5M.
  • Cowen and Company's ten largest holdings make up 40% of its $1.21B portfolio in Q2 2023.
  • Cowen and Company opened 182 new positions and closed 163 in Q2 2023.
  • Cowen and Company's portfolio value rose 42% quarter-over-quarter to $1.21B.

Based on Cowen and Company's 13F filing for Q2 2023, filed 7 Aug 2023.